Additional European Equity News

Boohoo (DEBS LN) - Co. raises FY27 Adj. EBITDA to "double digit %". (Boohoo) 

Bayer (BAYN GY) - Kerendia approved in EU for new indication in adult patients with heart failure with LVEF ≥40%. (Bayer) 

Glencore (GLEN LN) - Canada and Quebec are reportedly close to a deal with Glencore to keep the Horne copper smelter open, after the company threatened closure due to stricter arsenic emission rules. Authorities are offering regulatory concessions—delaying tougher limits—and considering around CAD 150mln in financial support to fund pollution-control upgrades. (Bloomberg) 

GSK (GSK LN) - Exdensur approved for severe asthma in China. Exdensur is the first and only ultra-long-acting biologic in China for the treatment of severe asthma with an eosinophilic phenotype. Elsewhere, Bepirovirsen accepted for regulatory review in China as a potential first-in-class functional cure for chronic hepatitis B. (GSK) 

UMG (UMG NA) - Co. announces a EUR 500mln share buyback programme. (UMG)

M&G (MNG LN) - Co. says its portfolio has been "insulated" from rate volatility. (Newswires) 

Metso (METSO FH) - Co. signs a "major" agreement with Southern Peru Copper. (Newswires) 

Robert Walters (RWA LN) - CFO Bower to retire. (Robert Walters) 

Skanska (SKAB SS) – Co. builds a new high school in Washington; USD 99mln contract booked in Q1’26. (Skanska)

Compass (CPG LN) upgraded to Neutral from Underperform at BNP Paribas

Segro (SGRO LN) upgraded to Neutral from Sell at Kempen